Synthesis and anti-tumor activity evaluation of novel chalcone derivatives as potential HDAC6 inhibitors
{{output}}
Histone deacetylase inhibitors (HDACis) are a class of epigenetic drugs that, as the name suggests, inhibit histone deacetylases (HDACs), which are anticancer therapeutic targets. Several studies have investigated hydroxamic acid HDACi. However, most anti-canc... ...
